AZN: EMA's CHMP Backs Leqvio
AstraZeneca's Leqvio receives positive opinion from EMA's CHMP for marketing authorisation change
AZN AstraZeneca EMA's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for AstraZeneca's Leqvio